Latest Breaking News On - Egeneronv celltrion - Page 1 : comparemela.com

On Friday, January 20, 2024, Regeneron Pharmaceuticals, Inc. ("Regeneron") filed an ex parte application for a scheduling order setting the schedule for preliminary injunction proceedings or, in the alternative, an emergency status conference.

United statesNorthern districtWest virginiaSamsung bioepisCelltrion incRegeneron pharmaceuticals incAmgen incJudicial panelUs district courtSamsung bioepis coJudicial panel on multidistrictMylan pharmaceuticals incBiocon biologics incRegeneron pharmaceuticalsCentral districtChief judge kleeh